🔬 Finnish researchers from the University of Turku have identified a new way to predict the recurrence and mortality risk of oral cancers. They found that the surface cells of lymphatic vessels within the tumor contain proteins indicating cell division, which strongly predicts disease progression.

📈 This discovery, based on samples from approximately 300 Finnish patients, revealed that a higher number of dividing lymphatic vessels in early-stage oral cancers is a better predictor of cancer recurrence and death than previously known factors.

💡 The findings, published in Cell Reports Medicine, could lead to a practical clinical tool to better identify high-risk patients, allowing for more targeted adjuvant therapies and potentially avoiding unnecessary treatments for those with a better prognosis.

#OralCancer #MedicalResearch #CancerDiagnosis

Research shows that antiviral and antibacterial bioengineered chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies

Read Full Article

#OralCancer #CancerResearch #OralHealth

Painless Swab Detects Oral Cancers in an Hour, With Over 95% Accuracy | The quantitative Malignancy Index Diagnostic System (qMIDS), involves using a brush to swab the suspect lesion, and then analyzing it for signs of mRNA expression from four specific genes linked to oral cancer.

Read Full Article

#OralCancer #EarlyDetection #qMIDS

🔬 Breakthrough Non-Invasive Oral Cancer Test Developed: Scientists have created a new test that can accurately detect early-stage oral cancer using a simple mouth swab. Results are available within an hour, offering a rapid and painless alternative to painful biopsies.

⏱️ High Accuracy Achieved: The new quantitative Malignancy Index Diagnostic System (qMIDS) test demonstrated an overall accuracy of 95.5% in trials with 545 patients, with false positive and negative rates below 5%.

👍 Revolutionary Patient Monitoring: This brush swab test allows for regular, systematic monitoring of patients with potentially pre-malignant lesions, enabling earlier cancer detection and improved patient outcomes.

✅ Future Availability: Researchers are working to commercialize the qMIDS test, with plans for clinical use within the next two years.

#OralCancer #MedicalInnovation #CancerDetection